Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Aspects of Healthcare that Have Evolved for Good in the Wake of COVID

Although many people are hoping for things to return to normal after the pandemic is over, the healthcare industry is one area that won’t look the same in a post-pandemic world. In a matter of weeks, the entire industry was upended in an attempt to save the lives of those affected by the coronavirus –…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Aspects of Healthcare that Have Evolved for Good in the Wake of COVID

Although many people are hoping for things to return to normal after the pandemic is over, the healthcare industry is one area that won’t look the same in a post-pandemic world. In a matter of weeks, the entire industry was upended in an attempt to save the lives of those affected by the coronavirus – and the ripples of these changes will affect the industry for years to come.

Here, we’ll look at three aspects of healthcare that have been transformed by the COVID-19 pandemic.

Trend #1: A Greater Emphasis on Patient-Focused Care

Before the pandemic, receiving care was a process that often took longer than necessary, with administrative bottlenecks and wait times at an all-time high.

However, because of the coronavirus crisis, healthcare leaders are understanding the importance of people receiving care when they need it. After all, any lack in urgency could easily cost someone their life.

The focus on healthcare is slowly transitioning to a patient-focused model, where care and overall service revolves around the care receiver rather than the provider. As a result, features like easily accessible electronic forms and prescription delivery services encourage patients to get more involved with their care and improve their overall experience.

Trend #2: Elevated Telehealth and Remote Patient Monitoring

Not long ago, telehealth was seen as inferior to in-person care and a last resort option for many patients. Nowadays, it’s essential to the health and safety of both patients and care providers.

Because telehealth doctors don’t have the same logistical restraints that in-person providers have, patients can often secure telehealth appointments much sooner. They can also be treated wherever they are without risking infection from others, especially if they’re immunocompromised.

On the other hand, those who do have COVID can be treated while limiting the risk of exposure to those around them.

Trend #3: Increased In-Home Care for the Elderly

Many families feel uneasy about bringing their relatives to a nursing home, in part because of the lack of transparency around the care they receive. However, the pandemic has highlighted another reason to reconsider the idea.

New York Times article revealed that 34% of all American COVID deaths at the time of writing – a staggering 152,000 – were linked to nursing homes. A crowd of people living together in a cramped space makes it easier for diseases to spread, and weakened immune systems result in more deaths.

Although sickness is an inevitable part of life, families are now choosing to reduce the risk by keeping their relatives close to home. Others even have their loved ones move in with them. Additionally, they may decide to hire in-home medical help to ensure that their relatives get the best level of care possible.

Champion: Medical Seating Designed with Evolution in Mind

With the standards of healthcare changing right before our eyes, your patients deserve a level of care that can adapt just as quickly.

Champion has developed medical chairs that can be used in a variety of settings, from acute care, emergent procedures and multipurpose patient needs to in-home treatment. Their versatility allows providers to administer care in a variety of settings, while their user-centric design improves the level of comfort of the patients that use them.

To learn more about Champion’s products and the benefits they offer, visit www.championchair.com/applications.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

The Centers for Medicare & Medicaid Services (CMS) has established a new Office of Health Technology and Products. This office assumes over 90 responsibilities to lead federal health IT strategy, focusing on areas like AI, interoperability, and claims modernization.

  • 01CMS's new office centralizes health tech authority, focusing on AI and interoperability.
  • 02The office takes on over 90 responsibilities to modernize claims processes.
  • 03CMS aims to lead federal health IT strategy with its new dedicated office.

Aug 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512